NASDAQ:ACHV
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. reported net income of −$54.6M in fiscal 2025. Free cash flow was −$49.5M, and the diluted share count rose 35.9%.Summary generated from Achieve Life Sciences, Inc.'s SEC filings. Latest annual report filed Mar 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−257.7%
Debt / equityn/a
Free cash flow−$49.5M
FCF marginn/a
Share count change+35.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | −33 | −42 | −30 | −40 | −55 |
| Free cash flow | n/a | n/a | −25 | n/a | −49 |
Recent filings
- 4Insider transaction report
Oct 6, 2026 - 8-KDirector or officer change
Oct 1, 2026 - 4Insider transaction report
Aug 21, 2026 - 8-KOther events
Aug 14, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026 - 8-KAmendment to articles or bylaws
Jul 6, 2026 - DEF 14AProxy statement
Jun 8, 2026